Hong Kong Water Utilities Stock News

Weichai Power (SEHK:2338) just signed a new manufacturing licence agreement to produce Ceres’ solid oxide fuel cell technology. This deal enables Weichai to target new sectors, such as AI data centres, commercial buildings, and industrial markets. See our latest analysis for Weichai Power. Weichai Power’s renewed partnership with Ceres comes as investor momentum is rapidly building. The company’s shares are up 31% over the past month and 66% year-to-date. Supported by standout business...

Cathay Pacific Airways (SEHK:293) revealed that its Board of Directors will evaluate a share repurchase program. This signals a review of options to return value to shareholders and may reflect management's optimism about the company's outlook. See our latest analysis for Cathay Pacific Airways. Cathay Pacific Airways’ share price gained real traction recently, rising 15.2% in the last month and now up 30.2% year-to-date, as the market digests both a resilient recovery and the newly...

Man Wah Holdings (SEHK:1999) has released its half-year earnings, showing a dip in sales but a small uptick in net income and earnings per share compared to the prior year. These mixed results may have caught investors’ attention. See our latest analysis for Man Wah Holdings. Man Wah Holdings' latest earnings, showing stable profits amid slightly weaker sales, appear to have boosted investor confidence. The share price climbed 15.3% over the past month and total shareholder return reached...

Vtech Holdings (SEHK:303) attracted investor focus after announcing both lower sales and net income for the half year ended September 2025. The company noted that while improvements are expected ahead, full-year revenue could still end up declining. See our latest analysis for Vtech Holdings. Despite the softer sales and earnings figures, Vtech Holdings’ share price has held up well, up 16.25% year-to-date. This reflects optimism around management’s guidance for improvement in the second...

CIMC Enric Holdings (SEHK:3899) has announced plans to activate a previously approved mandate, which allows the company to repurchase up to 1.5% of its issued shares. This move is aimed at boosting shareholder value and supporting market sentiment. See our latest analysis for CIMC Enric Holdings. After a solid share buyback announcement, CIMC Enric Holdings has seen momentum build, with the stock climbing 16.5% over the last 90 days. Its total shareholder return over the past year stands at a...

Johnson Electric Holdings Limited announced its half-year 2025 results, reporting net income of US$133.26 million on sales of US$1.83 billion, alongside an interim dividend of HK$0.17 per share for the period ended September 30, 2025. The company's ability to increase net income despite slightly lower sales highlights a focus on profitability and shareholder returns. We’ll examine how Johnson Electric’s commitment to both earnings growth and dividend payments shapes its overall investment...

Shanghai Henlius Biotech (SEHK:2696) is in focus after the US FDA approved its Biologics License Application for POHERDY. This approval makes POHERDY the first pertuzumab biosimilar available in the US through a partnership with Organon. See our latest analysis for Shanghai Henlius Biotech. Henlius’s recent FDA approval comes on the heels of a remarkable run. After some profit-taking, the stock’s latest price is HK$65.25, and its year-to-date share price return is an eye-catching 177.66%...

JD Health International (SEHK:6618) delivered a strong set of third-quarter results, outpacing market forecasts for both revenue and profit. The company also rolled out new collaborations and initiatives that broaden its digital healthcare reach. See our latest analysis for JD Health International. JD Health International’s latest quarterly results have electrified its share price, delivering a 1-month share price return of 14.2% and driving its year-to-date gain to an impressive 162.9%. An...

CStone Pharmaceuticals (SEHK:2616) is in focus after two important pipeline updates landed this week. The company will showcase preclinical data for its CS2015 antibody at ACAAI 2025. In addition, CS2009 has cleared an IND milestone in China. See our latest analysis for CStone Pharmaceuticals. CStone’s share price has surged 148% year-to-date and delivered an exceptional 227% total shareholder return over the past year. This performance has been fueled in recent days by promising advances in...

As global markets navigate the aftermath of the longest U.S. government shutdown in history and fluctuating economic indicators, Asian markets are experiencing their own set of challenges and opportunities, with Chinese stocks retreating amid concerns over economic momentum and Japan's indices rising on policy expectations. In this environment, identifying growth companies with substantial insider ownership can be particularly appealing to investors seeking alignment between management...

As global markets navigate a complex landscape marked by mixed performances and economic uncertainties, the Asian market remains a focal point for investors seeking growth opportunities. Penny stocks, often seen as relics of earlier market days, continue to offer potential for significant returns, especially when backed by strong financial health and solid fundamentals. In this article, we explore several Asian penny stocks that stand out with robust balance sheets and promising prospects in...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

It's been a soft week for Wealthink AI-Innovation Capital Limited ( HKG:1140 ) shares, which are down 10%. But that...

Kidztech Holdings Limited ( HKG:6918 ) shares have had a horrible month, losing 25% after a relatively good period...

China Gas Holdings (HKG:384) has had a great run on the share market with its stock up by a significant 11% over the...

Key Insights Significant control over JD Logistics by public companies implies that the general public has more power...

By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at...

As Asian markets navigate a landscape marked by economic challenges and investor caution, the focus on insider ownership becomes increasingly relevant. In this context, companies with significant insider stakes can offer insights into potential growth opportunities, as they often reflect confidence from those closest to the business.

As global markets navigate a complex landscape marked by economic uncertainties and shifting investor sentiment, the Asian stock market presents intriguing opportunities for those seeking value. In this context, identifying stocks trading below their intrinsic value can offer potential for growth, especially as investors look to balance risk with the promise of long-term returns amidst current market conditions.

Earlier this week, China Resources Land announced it would sell approximately 49.5 million shares of China Resources Mixc Lifestyle Services for about HK$2 billion, reducing its stake from 72.29% to 70.12%. This transaction was executed at nearly a 10 percent discount to the previous closing price and is intended to raise funds for acquiring land reserves and covering development costs. We'll consider how this reduced ownership stake and discounted placement could influence the company's...

Yue Yuen Industrial (Holdings) reported earnings for the nine months ended September 30, 2025, with sales of US$6.02 billion and net income of US$278.72 million, both reflecting decreases compared to the same period last year. The declines in both sales and profitability suggest that operational challenges or shifting market demand may have impacted the company's core business during this period. We’ll explore how the dip in net income shapes Yue Yuen Industrial’s investment narrative and...

Prada (SEHK:1913) has seen its shares fluctuate this week, prompting investors to take a closer look at what is driving recent price action. The past month has delivered modest gains, raising some interesting valuation questions. See our latest analysis for Prada. Prada’s latest week of trading brought a mix of volatility and modest upward movement, with a 5.8% 7-day share price return standing out within an ongoing period of market recalibration. While momentum has been choppy lately, it’s...

Earlier in November 2025, CARsgen Therapeutics Holdings announced updated clinical data for its allogeneic CAR-T cell therapy candidates, CT0596 and CT1190B, revealing initially favorable safety and efficacy outcomes in heavily pretreated patients with relapsed/refractory multiple myeloma and non-Hodgkin’s lymphoma. An interesting insight is that some patients who had failed multiple previous advanced therapies achieved complete responses, highlighting the potential impact of these...

Semiconductor Manufacturing International Corporation ( HKG:981 ) shareholders are probably feeling a little...